Ibex® Design mAbs: Speed and quantity guaranteed* at a fixed price
Ibex® Design mAbs is a comprehensive program combining speed, guarantees* and quality, while minimizing risk, in the delivery of your CMC path to IND in only 11 months for your monoclonal antibodies.
If you are looking to gain maximum information on your drug candidate as early as possible, Ibex® Design mAbs delivers tox drug product in only 5 months so that you can perform toxicological studies before entering GMP manufacturing.
Our parallel cell line and drug substance process development, as well as our integrated drug substance and drug product program, are key to bringing your rapidly to the clinic.
Once you enroll in our Ibex® Design mAbs program, we will keep a manufacturing slot reserved for your clinical resupply and offer flexible drug product manufacturing, to further increase predictability in achieving timelines and material supply.
*For antibodies, from DNA transfection to delivery of IND-enabling CMC modules. Subject to terms and conditions.